Literature DB >> 19053779

Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Adam J T Smith1, Xiyun Zhang, Andrew G Leach, K N Houk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19053779      PMCID： PMC2646787          DOI： 10.1021/jm800498e

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  94 in total

1.  Class assignment of sequence-unrelated members of enzyme superfamilies by activity-based protein profiling.

Authors:  Nadim Jessani; Jason A Young; Sandra L Diaz; Matthew P Patricelli; Ajit Varki; Benjamin F Cravatt
Journal:  Angew Chem Int Ed Engl       Date:  2005-04-15       Impact factor: 15.336

Review 2.  Mechanism-based profiling of enzyme families.

Authors:  Michael J Evans; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

3.  Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding.

Authors:  Julian Tirado-Rives; William L Jorgensen
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

4.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

Authors:  A Ajay; W P Walters; M A Murcko
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

5.  Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.

Authors:  P Lorentzon; A Bayati; H Lee; K Andersson
Journal:  Ann N Y Acad Sci       Date:  1997-11-03       Impact factor: 5.691

6.  The rational design of suicide substrates of amine oxidases.

Authors:  M G Palfreyman; I A McDonald; P Bey; C Danzin; M Zreika; G A Lyles; J R Fozard
Journal:  Biochem Soc Trans       Date:  1986-04       Impact factor: 5.407

7.  New insights into the mechanistic details of the carbonic anhydrase cycle as derived from the model system [(NH(3))(3)Zn(OH)](+)/CO(2): how does the H(2)O/HCO(3)(-) replacement step occur?

Authors:  M Mauksch; M Bräuer; J Weston; E Anders
Journal:  Chembiochem       Date:  2001-03-02       Impact factor: 3.164

8.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

9.  Transition state analogues for enzyme catalysis.

Authors:  R Wolfenden
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

10.  Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators.

Authors:  Leggy A Arnold; Eva Estébanez-Perpiñá; Marie Togashi; Natalia Jouravel; Anang Shelat; Andrea C McReynolds; Ellena Mar; Phuong Nguyen; John D Baxter; Robert J Fletterick; Paul Webb; R Kiplin Guy
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157
View more
  42 in total

1.  Prediction of ligand-binding sites of proteins by molecular docking calculation for a random ligand library.

Authors:  Yoshifumi Fukunishi; Haruki Nakamura
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

2.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

3.  A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.

Authors:  Ziyad F Al-Rashid; Richard P Hsung
Journal:  Bioorg Med Chem Lett       Date:  2015-06-27       Impact factor: 2.823

Review 4.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

Review 5.  Developing irreversible inhibitors of the protein kinase cysteinome.

Authors:  Qingsong Liu; Yogesh Sabnis; Zheng Zhao; Tinghu Zhang; Sara J Buhrlage; Lyn H Jones; Nathanael S Gray
Journal:  Chem Biol       Date:  2013-02-21

6.  Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.

Authors:  Andrea Scarpino; György G Ferenczy; György M Keserű
Journal:  Methods Mol Biol       Date:  2021

7.  Two-component covalent inhibitor.

Authors:  Evan M Cornett; Yulia V Gerasimova; Dmitry M Kolpashchikov
Journal:  Bioorg Med Chem       Date:  2013-01-22       Impact factor: 3.641

8.  Potent, long-acting cyclopentane-1,3-Dione thromboxane (A2)-receptor antagonists.

Authors:  Xiaozhao Wang; Li Liu; Longchuan Huang; Katie Herbst-Robinson; Anne-Sophie Cornec; Michael J James; Shimpei Sugiyama; Marcella Bassetto; Andrea Brancale; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith; Kurt R Brunden; Carlo Ballatore
Journal:  ACS Med Chem Lett       Date:  2014-07-24       Impact factor: 4.345

9.  Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay.

Authors:  Andrew J Storaska; Jian P Mei; Meng Wu; Min Li; Susan M Wade; Levi L Blazer; Benita Sjögren; Corey R Hopkins; Craig W Lindsley; Zhihong Lin; Joseph J Babcock; Owen B McManus; Richard R Neubig
Journal:  Cell Signal       Date:  2013-09-14       Impact factor: 4.315

10.  Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors:  Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2017-09-28       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.